After nine years of grinding, Replit finally found its market. Can it keep it?

While AI coding startups like Cursor close brow-raising rounds on barely three years of existence, Replit's path to a $3 ...
Zacks Investment Research on MSN

Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains?

Recursion Pharmaceuticals (RXRX) shares ended the last trading session 8.2% higher at $5.52. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the ...